Losing hair?

Take part in a hair regrowth study.

Millions of men and women have androgenetic alopecia—the most common form of hair loss.

You may be able to take part in a clinical trial evaluating an investigational treatment that doctors and researchers are studying to see whether it may help with hair loss and support hair regrowth.

See if you qualify

The trial is now enrolling in Melbourne, Brisbane, and Sydney.

About The

Trial

The HEADLINE trial is a clinical trial evaluating the safety of the study drug, an investigational monoclonal antibody, in healthy adults with and without androgenetic alopecia (male and female pattern hair loss). The trial will also collect early information on how the investigational treatment may support hair growth in people with androgenetic alopecia.

The study drug is being investigated in ongoing clinical trials, and is not approved by the FDA or any other countries’ health or regulatory authority for the population or indication being investigated. This means that the safety and efficacy of the investigational treatment is still being studied in clinical trials.

Backed by Science.

Led by Experts.

This trial is being conducted by Absci, a biotechnology company developing treatments with the goal of developing potentially transformative treatments for diseases like androgenetic alopecia.

Professor Dr. Rodney Sinclair, world-renowned dermatologist and researcher on hair-loss, is one of the experts helping lead the way.

Why Participate

By participating in the HEADLINE trial, you may gain access to the latest research on a potential new treatment for androgenetic alopecia, along with trial-related care from experienced doctors and dermatology research teams.

Expert care

Receive trial-related care from experienced doctors and dermatology research teams.

No cost to you

There is no cost for participating, and you may be eligible to receive compensation.

Contribute to science

Help researchers explore a potential new treatment for hair loss backed by biotech innovation.

Clinical trial participant

Check Your Eligibility

Final eligibility is determined by the clinical trial team.

See if you qualify

Select Qualifying Criteria

Who may not be eligible to join

Final eligibility is determined by the clinical trial team.

See if you qualify

What to Expect

Clinical trial participant
1

See if you Qualify

Scroll down to complete a short online form. This helps the team see whether you may be eligible to participate.

2

Talk with the clinical trial team

If you may be eligible, a coordinator will contact you to review the trial in detail, answer questions, and, if you choose to continue, guide you through the informed consent process.

3

Screening visit & health checks

You'll attend an in-person screening visit for health checks, hair/scalp assessments, blood samples, and routine tests to confirm eligibility.

4

Clinical trial visits & follow-up

If you qualify, you’ll take part in scheduled trial visits. Some participants may have a short in‑clinic stay; your team will explain the schedule before you decide.

5

Compensation and Support

There is no cost for you to participate in the trial. Additionally, you may be eligible to receive compensation and your trial team will be available to support you. You can leave the trial at any time.

Clinical trial participant

What to Expect

Scroll down to complete a short online form. This helps the team see whether you may be eligible to participate.

If you may be eligible, a coordinator will contact you to review the trial in detail, answer questions, and, if you choose to continue, guide you through the informed consent process.

You'll attend an in-person screening visit for health checks, hair/scalp assessments, blood samples, and routine tests to confirm eligibility.

If you qualify, you’ll take part in scheduled trial visits. Some participants may have a short in‑clinic stay; your team will explain the schedule before you decide.

There is no cost for you to participate in the trial. Additionally, you may be eligible to receive compensation and your trial team will be available to support you. You can leave the trial at any time.

Where to Join

Find a participating site

Australia

Melbourne, VIC

Nucleus Network Melbourne

Melbourne, VIC

Sinclair Dermatology

Brisbane, QLD

Nucleus Network Brisbane

Sydney, NSW

Momentum Clinical Research St Leonards

Don't see a convenient location? More sites may open soon. Complete the "See If You Qualify" form below to join the waitlist.

See If You Qualify

Answer a few questions to see whether you may be eligible for the HEADLINE trial. If you may qualify, a trial coordinator will contact you to discuss next steps and schedule a screening visit at a participating site.

Melbourne, VIC
Brisbane, QLD
Sydney, NSW

See If You Qualify

Register Your Interest for The Hair Loss Screening Study

Find out if you’re eligible to join an upcoming clinical study focused on male pattern hair loss (androgenetic alopecia).

This form takes around 3–5 minutes to complete. Your information will remain confidential and is used only to assess your eligibility for current or future research studies.
Step 1 of 3
Contact Information




The phone number you have entered does not appear to be a valid active Australian phone number. Please check your details and enter a valid Australian phone number starting with +61

Nucleus Network does not currently conduct clinical trials in your state. If you would like to receive study information should this situation change, please complete and submit this form.
Personal Information

This includes registering your interest with the Centre for Clinical Studies, Q-Pharm or Nucleus Network

Please call us on 1800 243 733 or schedule a call.


What is your date of birth?
Day Month Year

You need to be at least 18 years old to participate in clinical trials.


cm

kg





















Step 2 of 3
Medical History

We define an allergy as severe if symptoms include mouth/throat/face swelling, shortness of breath or a whole-body rash, or if it required hospitalisation

We regularly have studies that allow participants who are (social) smokers.

We regularly have studies that allow for/require participants with asthma.



We regularly have studies that allow for/require participants with medical conditions.

Medications & Contraception Requirements

We regularly have studies that allow participants with depression that is well-managed on a stable dose of medication.

If the only prescription medication you currently use is hormonal contraception and/or Ventolin, please select No above. We regularly have studies that allow for participants who take a stable dose of prescription medication.


  • Abstinence from sex with anyone of the opposite sex for at least 2 months
  • Using a condom + your female sexual partner(s) using a separate form of birth control
  • You or your sexual partner(s) had a vasectomy/hysterectomy
  • Your sexual partner(s) are post-menopausal


Only you taking birth control or your partner(s) using a condom is not an acceptable option, but using both together is. The morning after pill is not an acceptable form of birth control.

  • Abstinence, by choice, from sex with anyone of the opposite sex for the last 2 months + remaining abstinent for at least 2 months after study participation
  • You using birth control + your male sexual partner(s) using a condom
  • You or your sexual partner(s) had a hysterectomy/vasectomy
  • You are post-menopausal



Step 3 of 3
Study Requirements







Referral Information



Consent to Information Use and Future Contact


See If You Qualify

Register Your Interest for The Hair Loss Screening Study

Find out if you’re eligible to join an upcoming clinical study focused on male pattern hair loss (androgenetic alopecia).

This form takes around 3–5 minutes to complete. Your information will remain confidential and is used only to assess your eligibility for current or future research studies.
Step 1 of 3
Contact Information




The phone number you have entered does not appear to be a valid active Australian phone number. Please check your details and enter a valid Australian phone number starting with +61

Nucleus Network does not currently conduct clinical trials in your state. If you would like to receive study information should this situation change, please complete and submit this form.
Personal Information

This includes registering your interest with the Centre for Clinical Studies, Q-Pharm or Nucleus Network

Please call us on 1800 243 733 or schedule a call.


What is your date of birth?
Day Month Year

You need to be at least 18 years old to participate in clinical trials.


cm

kg





















Step 2 of 3
Medical History

We define an allergy as severe if symptoms include mouth/throat/face swelling, shortness of breath or a whole-body rash, or if it required hospitalisation

We regularly have studies that allow participants who are (social) smokers.

We regularly have studies that allow for/require participants with asthma.



We regularly have studies that allow for/require participants with medical conditions.

Medications & Contraception Requirements

We regularly have studies that allow participants with depression that is well-managed on a stable dose of medication.

If the only prescription medication you currently use is hormonal contraception and/or Ventolin, please select No above. We regularly have studies that allow for participants who take a stable dose of prescription medication.


  • Abstinence from sex with anyone of the opposite sex for at least 2 months
  • Using a condom + your female sexual partner(s) using a separate form of birth control
  • You or your sexual partner(s) had a vasectomy/hysterectomy
  • Your sexual partner(s) are post-menopausal


Only you taking birth control or your partner(s) using a condom is not an acceptable option, but using both together is. The morning after pill is not an acceptable form of birth control.

  • Abstinence, by choice, from sex with anyone of the opposite sex for the last 2 months + remaining abstinent for at least 2 months after study participation
  • You using birth control + your male sexual partner(s) using a condom
  • You or your sexual partner(s) had a hysterectomy/vasectomy
  • You are post-menopausal



Step 3 of 3
Study Requirements







Referral Information



Consent to Information Use and Future Contact


Coming Soon

FAQ

See if you qualify
What is the investigational treatment?
The study drug is an investigational monoclonal antibody being studied for androgenetic alopecia (male and female pattern hair loss).
What is a clinical trial?
A clinical trial is a research trial that tests the safety and effectiveness of a new medicine. Participants are closely monitored by medical professionals throughout the trial duration.
What does participation involve?
Clinic visits for health checks and hair/scalp assessments. Some participants may have a short in‑clinic stay; your team will explain the schedule before you decide.
How long does the trial last?
Visit schedules vary by trial part. Your coordinator will walk you through the expected timeline during screening.
Are there costs or compensation?
There is no cost for trial‑related care, additionally participants may be eligible for compensation.
Can I stay on my current hair‑loss treatment?
Some medications or recent procedures may require a washout or could affect eligibility. Please complete the online eligibility questionnaire and speak with the trial team for guidance.
Who oversees safety?
The trial follows Good Clinical Practice and is reviewed by an independent ethics committee. Safety is monitored throughout.
Can I leave the trial?
Yes. Participation is voluntary, and you may leave at any time.